ASMicro 2018 Martin Scanlon
Monash Institute of Pharmaceutical Sciences, VIC, Australia
Presentations this author is a contributor to:
Dsb enzymes: promising anti-virulence drug targets for Gram-negative pathogens (#228)
6:30 PM
Rabeb Dhouib
Welcome Function & Poster Session I
Identification of small molecules as novel therapeutic options that suppress virulence in Neisseria gonorrhoeae and increase susceptibility to CAMPs (#45)
5:10 PM
Christopher A Mullally
Advances in Vaccinology and Therapeutics